ichorbio supplies what we believe is the largest range of research grade biosimilars available worldwide. Research grade means that our biosimilars are strictly for research use only (RUO) and not for diagnostic or therapeutic use. Our research grade biosimilars begin in 5mg sizes and go up to 50mg as a standard size. We can manufacture up to gram quantities on demand.

A-Z of our research grade biosimilars based on target:

Anti-4-1BB Biosimilars for RUO

Table of Contents

$718.00$4,161.00

Anti-5T4 Biosimilars for RUO

Anti-Amyloid Beta Biosimilars for RUO

Anti-Angiopoietin-2 Biosimilars for RUO

Anti-BCMA Biosimilars for RUO

Anti-C1s Biosimilars for RUO

Anti-CALCA / CALCB Biosimilars for RUO

Anti-Carbonic Anhydrase IX Biosimilars for RUO

Anti-CD3/CD20 Biosimilars for RUO

Anti-CD3/CD19 Biosimilars for RUO

Anti-CD3e Biosimilars for RUO

Anti-CD3e/CD20 Biosimilars for RUO

Anti-CD4 Biosimilars for RUO

Anti-CD14 Biosimilars for RUO

Anti-CD19 Biosimilars for RUO

Anti-CD20 Biosimilars for RUO

Anti-CD22 Biosimilars for RUO

Anti-CD25 Biosimilars for RUO

Anti-CD27 Biosimilars for RUO

Anti-CD28 Biosimilars for RUO

Anti-CD38 Biosimilars for RUO

Anti-CD40 Biosimilars for RUO

Anti-CD47 Biosimilars for RUO

Anti-CD52 Biosimilars for RUO

$718.00$4,161.00

Anti-CD70 Biosimilars for RUO

Anti-CD73 Biosimilars for RUO

Anti-CD79b Biosimilars for RUO

Anti-CEA/CD3 Biosimilars for RUO

Anti-CEACAM5 Biosimilars for RUO

Anti-CEACAM6 Biosimilars for RUO

Anti-cGRP Biosimilars for RUO

Anti-cGRP Receptor Biosimilars for RUO

Anti-Claudin 18.2 Biosimilars for RUO

Anti-Complement Protein C5 Biosimilars for RUO

Anti-CTLA-4 Biosimilars for RUO

Anti-DLL3 Biosimilars for RUO

Anti-EGFR Biosimilars for RUO

$718.00$4,161.00

Anti-ErbB2 Biosimilars for RUO

Anti-FcRn Biosimilars for RUO

Anti-FGFR Biosimilars for RUO

Anti-FGFR2b Biosimilars for RUO

Anti-GM-CSF Biosimilars for RUO

Anti-GPC3 Biosimilars for RUO

Anti-GPIIb/GPIIIa Biosimilars for RUO

Anti-IgE Biosimilars for RUO

Anti-IL-4R Biosimilars for RUO

Anti-IL-5 Biosimilars for RUO

Anti-IL-6 Biosimilars for RUO

Anti-IL-6 Receptor Biosimilars for RUO

Anti-IL-12 / IL-23 Biosimilars for RUO

Anti-IL-13 Biosimilars for RUO

Anti-IL-17 Biosimilars for RUO

Anti-IL-23 Biosimilars for RUO

Anti-IL-33 Biosimilars for RUO

Anti-Integrin a4 Biosimilars for RUO

Anti-LAG3 biosimilars for RUO

Anti-LOXL2 biosimilars for RUO

Anti-MSLN biosimilars for RUO

Anti-Nectin-4 biosimilars for RUO

Anti-NKG2A biosimilars for RUO

Anti-PCSK9 Biosimilars for RUO

Anti-PD-1 Biosimilars for RUO

ichorbio has developed research grade versions of both nivolumab and pembrolizumab. In November 2021 ichorbio added Sintilimab, Tislelizumab and Toripalimab to our group of anti-PD-1 biosimilars.

Anti-PD-L1 Biosimilars for RUO

ichorbio has created research use versions of atezolizumab, avelumab. In October 2021 we introduced durvalumab to our portfolio as our latest PD-L1 biosimilar.

Anti-RANKL Biosimilars for RUO

$718.00$4,161.00

Anti-RSV-F Biosimilars for RUO

Anti-SIGLEC3 Biosimilars for RUO

Anti-SIGLEC15 Biosimilars for RUO

Anti-TACSTD2 Biosimilars for RUO

Anti-TGF beta Biosimilars for RUO

Anti-TIGIT Biosimilars for RUO

Anti-TIM-3 Biosimilars for RUO

Anti-TNF alpha biosimilars for RUO

There are currently three anti-TNF antibodies that have been approved to inhibit TNF alpha: infliximab, adalimumab and golimumab. ichorbio currently sells research grade adalimumab & infliximab biosimilars.

Anti-TNFSF13B Biosimilars for RUO

Anti-VEGF Biosimilars for RUO

ichorbio has developed two VEGF inhibitors – Aflibercept and Bevacizumab.

Anti-VEGFR2 Biosimilars for RUO

Anti-VISTA Biosimilars for RUO

ichorbio is releasing new research grade biosimilars on a weekly basis. If you have any specific requests for new products please contact us at hello@ichor.bio.